日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

What's in a Label? Is Diagnosis the Start or the End of Clinical Reasoning?

标签里有什么?诊断是临床推理的开始还是结束?

Ilgen, Jonathan S; Eva, Kevin W; Regehr, Glenn

Locoregional treatment outcomes after multimodality management of inflammatory breast cancer

炎性乳腺癌多模式治疗后的局部区域治疗结果

Bristol, Ian J; Woodward, Wendy A; Strom, Eric A; Cristofanilli, Massimo; Domain, Delora; Singletary, S Eva; Perkins, George H; Oh, Julia L; Yu, Tse-Kuan; Terrefe, Welela; Sahin, Aysegul A; Hunt, Kelly K; Hortobagyi, Gabriel N; Buchholz, Thomas A

Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged <or=55 years

H2AFX启动子区域的基因变异与55岁及以下非西班牙裔白人女性散发性乳腺癌的风险相关。

Lu, Jiachun; Wei, Qingyi; Bondy, Melissa L; Brewster, Abenaa M; Bevers, Therese B; Yu, Tse-Kuan; Buchholz, Thomas A; Meric-Bernstam, Funda; Hunt, Kelly K; Singletary, S Eva; Wang, Li-E

Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways

乳腺癌手术患者静脉血栓栓塞的发生率及预防(按临床路径治疗)

Andtbacka, Robert H I; Babiera, Gildy; Singletary, S Eva; Hunt, Kelly K; Meric-Bernstam, Funda; Feig, Barry W; Ames, Frederick C; Ross, Merrick I; Dejesus, Yvette; Kuerer, Henry M

Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy

新辅助化疗后患者,体格检查、超声检查和乳腺X线摄影预测残余病理肿瘤大小的准确性

Chagpar, Anees B; Middleton, Lavinia P; Sahin, Aysegul A; Dempsey, Peter; Buzdar, Aman U; Mirza, Attiqa N; Ames, Fredrick C; Babiera, Gildy V; Feig, Barry W; Hunt, Kelly K; Kuerer, Henry M; Meric-Bernstam, Funda; Ross, Merrick I; Singletary, S Eva

Treatment trends in early-stage invasive lobular carcinoma: a report from the National Cancer Data Base

早期浸润性小叶癌的治疗趋势:来自国家癌症数据库的报告

Singletary, S Eva; Patel-Parekh, Lina; Bland, Kirby I

Rating the risk factors for breast cancer

对乳腺癌风险因素进行评级

Singletary, S Eva